Speaker

Prof. Yi-Long Wu is a tenured professor of Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences and Guangdong Lung Cancer Institute. He is the Past President of Chinese Society of Clinical Oncology (CSCO, 2013-2017), the President of Chinese Thoracic Oncology Group(C-TONG). He served as a Member of Board of Directors of the International Association Study of Lung Cancer (IASLC) from 2013-2017 and a past Member of staging committee of the IASLC (2009-2017), conference Chair of the 2020 World Conference on Lung Cancer, Chair of the Joint IASLC-CSCO-CAALC Session at WCLC (2013-2023).

He graduated from Sun Yat-sen University of Medical Sciences in 1982 and completed his thoracic surgery training in Germany in 1989. His main research interests are the multidisciplinary therapy on lung cancer in translation medicine and evidence-based medicine in oncology. He plays a leadership role in Chinese lung cancer clinical research and has been the Principal Investigator or Co-PI of more than 50 international or national multicenter clinical trials. He has contributed 20 books on cancer and has published more than 500 articles in peer-reviewed journals including Engl J Med, Nat Med, J Clin Oncol, Lancet Oncol, Ann Oncol, Cancer Cell and J Thorac Oncol. He played important role in adjuvant target treatment for resected NSCLC. ALINA, ADAURA, ADJUVANT/CTONG1104 and EMERGING/CTONG1103 were the most important papers in this field. He also serves on the editorial boards of Nature Review Clinical Oncology, Annual of Oncology, Lung Cancer, Annals of Surgical Oncology.

He received the IASLC Science/Paul A. Bunn, Jr. MD awards in 2015 and Awards of Highly Cited Research in the field of Clinical Medicine 2018- 2023.

« Go Back